Clinical use of novel biomarkers in heart failure: towards personalized medicine.
about
Soluble ST2 and Galectin-3: What We Know and Don't Know Analytically.Clinical utility of antigen carbohydrate 125 in heart failure.Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic review.Proteomics of pediatric heart failure: from traditional biomarkers to new discovery strategies.Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway.Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.Labeling galectin-3 for the assessment of myocardial infarction in rats.Optimizing clinical use of biomarkers in high-risk acute heart failure patients.Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.Biomarkers and personalized therapy in chronic kidney diseases.Palliative Care in the Management of Patients with Advanced Heart Failure.Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.
P2860
Q37229321-D80ADE35-0843-4606-BF97-B7B5E0D3E504Q38127350-9ED87F6C-DB22-4832-ADA8-93AF961E36B1Q38232810-009FACE0-D037-4B92-913E-5F64A7B08F93Q38588156-66A8EBAD-C0B3-48FB-8F94-EC92B93DFD5BQ38705811-0ACC3A31-762F-48F5-824B-CAE13297AD1BQ40084619-899DF210-2853-48EA-A4AA-CCD7F7EAED28Q40311889-FDEC0407-64DA-43CB-A92C-8531B74441C6Q40359671-2B3D65A7-0670-41E6-BDEF-18B2262F9917Q40777024-691F083D-BF40-4D15-B73F-FDD567F3B83AQ40792117-8E80B94D-4219-4894-891F-EB3C692E0A68Q41074638-282323DD-8A2B-4945-9296-A22B6ABDBE0CQ41165768-AA374A92-68DD-49DE-A056-F770A933103FQ42662118-863F9299-2156-4FCD-A000-A166D1D7C3A7Q47739995-5BAE3B29-BEA0-4D64-B612-4B8487376595Q55610979-2B364FBF-2065-46E1-955F-9C9070319503
P2860
Clinical use of novel biomarkers in heart failure: towards personalized medicine.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical use of novel biomarkers in heart failure: towards personalized medicine.
@en
type
label
Clinical use of novel biomarkers in heart failure: towards personalized medicine.
@en
prefLabel
Clinical use of novel biomarkers in heart failure: towards personalized medicine.
@en
P2860
P1476
Clinical use of novel biomarkers in heart failure: towards personalized medicine.
@en
P2093
Adriaan A Voors
Daniela Schmitter
P2860
P2888
P304
P356
10.1007/S10741-013-9396-5
P50
P577
2014-05-01T00:00:00Z